Janice Mehnert: There goes another Mount Sinai Health System resident making waves in oncology
Janice Mehnert, Associate Director For Clinical Research at
“There goes another Mount Sinai Health System resident making waves in oncology. Tanya Dorff was stellar when she was my senior resident and continues to be.”
Quoting Sumanta K. Pal‘s post:
“So proud of the superteam of Tanya Dorff and Saul Priceman – what an amazing paper in Nature Medicine. Have witnessed this duo forging the ultimate clinical/translational partnership in conducting this study over almost a decade. We often talk about bench to bedside, but this is a true example of it. We will miss Saul as he transitions to USC Norris Comprehensive Cancer Center to direct cell therapy, but hoping we can keep the collaborations going here at city of hope.!”
Source: Janice Mehnert/X and Sumanta K. Pal/X
Sumanta (Monty) Pal, MD, is a medical oncologist and an expert in genitourinary cancers at the City of Hope Comprehensive Cancer Center in Los Angeles. He serves as the co-director of the Kidney Cancer Program and leads the Kidney and Bladder Cancer Disease Team at City of Hope. He specialises in kidney, bladder, and prostate cancers.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023